PEOPLE - Johnson & Johnson (US) announces appointments:
This article was originally published in Clinica
Johnson & Johnson (New Brunswick, New Jersey) has announced two appointees to the office of chairman. William Weldon will replace Ralph Larson, who is set to retire in July, as chairman and CEO. Mr Weldon, who will be the sixth chairman in the company's 116-year history, joined the company in 1971 and most recently served as an executive committee member and worldwide chairman. James Lenehan, who joined the company in 1976, has been appointed as president in addition to his current role as vice-chairman. Mr Lenehan replaces Robert Wilson, who will continue to serve on the board until 2003.
You may also be interested in...
Data show Opdivo/Cabometyx combo bests Sutent for overall and progression-free survival and response endpoints in first-line RCC. Exelixis CEO says comparison to Sutent is standard control and allows better comparison to other combo regimens.
ES: Public Company Edition: Fifty biopharma companies launched initial public offerings in the US last year and there have been 52 so far in 2020, including Metacrine, Dyne, Athira and COMPASS.
In an update to stakeholders, the US FDA says regulators can successfully evaluate a firm’s performance, allowing it to eventually get medical software to market in the agency’s Pre-Cert Program.